Lee J, Lee J, Hong YS, Lee G, et al. Validation of the IASLC Residual Tumor Classification in Patients with Stage III-N2 Non-small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed by Surgery. Ann Surg 2022 Feb 15. pii: 00000658-900000000-93081.
PMID: 35166266